Thomas Slusarczyk is a securities and corporate lawyer who represents public and private companies with securities matters (including, SEC registration statement filings, IPO's, reverse mergers, private investment in public equity (PIPE) transactions, rights offerings, Regulation D and S offerings, Sarbanes-Oxley compliance and blue sky filings), mergers & acquisitions, joint ventures, dispositions, and general corporate matters. Mr. Slusarczyk also advises public companies (both foreign and domestic) regarding compliance with its 1934 Exchange Act requirements, including all periodic filings on Forms 10-K, 10-Q and 8-K (Forms 20-F and 6-K for foreign private issuers), and proxy statements, as well as, other regulatory and other filing requirements with the SEC, NYSE, NASDAQ, NYSE AMEX and FINRA.
Prior to joining Anslow & Jaclin, Mr. Slusarczyk represented clients in corporate and securities matters for the law firm DLA Piper LLP in New York. He was also in-house corporate development counsel for Deutsche Bank AG in New York, advising on M&A transactions for the global bank. Mr. Slusarczyk has also represented General Electric Healthcare on healthcare compliance matters, including FDA compliance, advising on the AdvaMed Code of Ethics, the Anti-kickback Statute and Stark Law compliance.
Mr. Slusarczyk obtained a B.S degree in engineering from Western Michigan University and his Juris Doctor from Syracuse University College of Law, where he was an editor on the Syracuse Law Review.
He is a member of the New York state bar.